echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Liantuo Bio has introduced over 200 million US dollars!

    Liantuo Bio has introduced over 200 million US dollars!

    • Last Update: 2022-05-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 20, the official website of the Center for Drug Evaluation (CDE) of the China National Medical Products Administration announced that a new class 2.


    Screenshot source: CDE official website

    According to public information, Nanobiotix is ​​a late-stage clinical development biotechnology company dedicated to bringing new treatment options to patients through physical principles-based treatments


    The physical mechanism of action of NBTXR3 is designed to be activated by radiotherapy, induce massive tumor cell death within the injected tumor, and subsequently trigger an adaptive immune response and long-term anticancer memory


    In May 2021, LianBio announced a partnership with Nanobiotix to obtain an exclusive license to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore and Thailand


    For the HNSCC indication, NBTXR3 has previously produced consistent safety data and early indications of efficacy in a Phase 1 dose escalation and dose expansion study


    Head and neck squamous cell carcinoma is a heterogeneous malignancy


    References:

    [1] The official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.